These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 29277543)
1. Microfluidics for producing poly (lactic-co-glycolic acid)-based pharmaceutical nanoparticles. Li X; Jiang X Adv Drug Deliv Rev; 2018 Mar; 128():101-114. PubMed ID: 29277543 [TBL] [Abstract][Full Text] [Related]
2. Translating the fabrication of protein-loaded poly(lactic-co-glycolic acid) nanoparticles from bench to scale-independent production using microfluidics. Roces CB; Christensen D; Perrie Y Drug Deliv Transl Res; 2020 Jun; 10(3):582-593. PubMed ID: 31919746 [TBL] [Abstract][Full Text] [Related]
3. Microfluidic Manufacturing of Multitargeted PLGA/PEG Nanoparticles for Delivery of Taxane Chemotherapeutics. Martins C; Sarmento B Methods Mol Biol; 2020; 2059():213-224. PubMed ID: 31435924 [TBL] [Abstract][Full Text] [Related]
4. Preparation of size-tunable sub-200 nm PLGA-based nanoparticles with a wide size range using a microfluidic platform. Bao Y; Maeki M; Ishida A; Tani H; Tokeshi M PLoS One; 2022; 17(8):e0271050. PubMed ID: 35925917 [TBL] [Abstract][Full Text] [Related]
5. Production of 5-fluorouracil-loaded PLGA nanoparticles with toroidal microfluidic system and optimization of process variables by design of experiments. Turkmen Koc SN; Conger E; Ozturk S; Eroglu I; Ulubayram K Int J Pharm; 2024 Sep; 662():124501. PubMed ID: 39053677 [TBL] [Abstract][Full Text] [Related]
6. Development and optimization of microfluidic assisted manufacturing process to produce PLGA nanoparticles. Chiesa E; Bellotti M; Caimi A; Conti B; Dorati R; Conti M; Genta I; Auricchio F Int J Pharm; 2022 Dec; 629():122368. PubMed ID: 36343906 [TBL] [Abstract][Full Text] [Related]
7. Brinzolamide loaded core-shell nanoparticles for enhanced coronial penetration in the treatment of glaucoma. Song J; Zhang Z J Appl Biomater Funct Mater; 2020; 18():2280800020942712. PubMed ID: 33151769 [TBL] [Abstract][Full Text] [Related]
8. Design of PLGA nanoparticles for sustained release of hydroxyl-FK866 by microfluidics. Bai X; Tang S; Butterworth S; Tirella A Biomater Adv; 2023 Nov; 154():213649. PubMed ID: 37820459 [TBL] [Abstract][Full Text] [Related]
10. Controllable Microfluidic Production of Drug-Loaded PLGA Nanoparticles Using Partially Water-Miscible Mixed Solvent Microdroplets as a Precursor. Xu J; Zhang S; Machado A; Lecommandoux S; Sandre O; Gu F; Colin A Sci Rep; 2017 Jul; 7(1):4794. PubMed ID: 28684775 [TBL] [Abstract][Full Text] [Related]
11. Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospectives. Pandita D; Kumar S; Lather V Drug Discov Today; 2015 Jan; 20(1):95-104. PubMed ID: 25277320 [TBL] [Abstract][Full Text] [Related]
12. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound. Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063 [TBL] [Abstract][Full Text] [Related]
13. Microfluidic Assisted Nanoprecipitation of PLGA Nanoparticles for Curcumin Delivery to Leukemia Jurkat Cells. Leung MHM; Shen AQ Langmuir; 2018 Apr; 34(13):3961-3970. PubMed ID: 29544247 [TBL] [Abstract][Full Text] [Related]
14. The distribution of cell-penetrating peptides on polymeric nanoparticles prepared using microfluidics and elucidated with small angle X-ray scattering. Streck S; Clulow AJ; Nielsen HM; Rades T; Boyd BJ; McDowell A J Colloid Interface Sci; 2019 Nov; 555():438-448. PubMed ID: 31400536 [TBL] [Abstract][Full Text] [Related]
15. Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics. Ding D; Zhu Q Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():1041-1060. PubMed ID: 30184728 [TBL] [Abstract][Full Text] [Related]
16. Computational design of Phe-Tyr dipeptide and preparation, characterization, cytotoxicity studies of Phe-Tyr dipeptide loaded PLGA nanoparticles for the treatment of hypertension. Kecel-Gündüz S; Budama-Kilinc Y; Cakir Koc R; Kökcü Y; Bicak B; Aslan B; Özel AE J Biomol Struct Dyn; 2018 Aug; 36(11):2893-2907. PubMed ID: 28835169 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and Statistical Optimization of Poly (Lactic-Co-Glycolic Acid) Nanoparticles Encapsulating GLP1 Analog Designed for Oral Delivery. Ismail R; Sovány T; Gácsi A; Ambrus R; Katona G; Imre N; Csóka I Pharm Res; 2019 May; 36(7):99. PubMed ID: 31087188 [TBL] [Abstract][Full Text] [Related]
18. The roadmap to micro: Generation of micron-sized polymeric particles using a commercial microfluidic system. Cruz-Acuña M; Kakwere H; Lewis JS J Biomed Mater Res A; 2022 May; 110(5):1121-1133. PubMed ID: 35073454 [TBL] [Abstract][Full Text] [Related]
19. Customizing poly(lactic-co-glycolic acid) particles for biomedical applications. Swider E; Koshkina O; Tel J; Cruz LJ; de Vries IJM; Srinivas M Acta Biomater; 2018 Jun; 73():38-51. PubMed ID: 29653217 [TBL] [Abstract][Full Text] [Related]
20. A comparative assessment of continuous production techniques to generate sub-micron size PLGA particles. Operti MC; Fecher D; van Dinther EAW; Grimm S; Jaber R; Figdor CG; Tagit O Int J Pharm; 2018 Oct; 550(1-2):140-148. PubMed ID: 30144511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]